清晨好,您是今天最早来到科研通的研友!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您科研之路漫漫前行!

Hepatitis B virus DNA levels and overall survival in hepatitis B‐related hepatocellular carcinoma patients with low‐level viremia

医学 危险系数 肝细胞癌 乙型肝炎病毒 内科学 置信区间 病毒血症 乙型肝炎 胃肠病学 免疫学 病毒
作者
Tae‐Se Kim,Dong Hyun Sinn,Wonseok Kang,Geum‐Youn Gwak,Yong‐Han Paik,Moon Seok Choi,Joon Hyeok Lee,Kwang Cheol Koh,Seung Woon Paik
出处
期刊:Journal of Gastroenterology and Hepatology [Wiley]
卷期号:34 (11): 2028-2035 被引量:22
标识
DOI:10.1111/jgh.14750
摘要

Abstract Background and Aim Clinical course of hepatitis B virus (HBV)‐related hepatocellular carcinoma (HCC) patients presenting with low‐level viremia (LLV) is unclear. Methods A total of 565 HBV‐related HCC patients with LLV (detectable but HBV DNA ≤ 2000 IU/mL) at the time of HCC diagnosis were analyzed. Based on patterns of HBV DNA levels during follow‐up, patients were categorized into three groups: maintained virologic remission (MVR), LLV, and flare. Overall survival was compared between those three groups. Results During a median 4.5 years of follow‐up, 33% showed MVR, 39% showed LLV, and 28% experienced flare. The overall survival differed between MVR, LLV, and flare groups (5‐year overall survival: 74.3%, 67.3%, and 61.7%, respectively, 0.015). The patterns of HBV DNA levels were independent factors associated with overall survival, along with age, antiviral treatment, Barcelona clinic liver cancer stage, and initial treatment modality. Flare group showed increased risk of mortality (adjusted hazard ratio [HR] 1.71, 95% confidence interval [CI] 1.15–2.55) compared with MVR group, while the risk was statistically marginal for the LLV group (adjusted HR 1.39, 95% CI 0.95–2.04). During follow‐up, 183 patients (32.4%) newly started antiviral therapy (AVT) at LLV. Flare risk was significantly lower among patients who started AVT at LLV compared with those who did not (adjusted HR 0.26, 95% CI 0.17–0.38). Conclusions Among HBV‐related HCC patients with LLV, flare was frequent during follow‐up and was associated with poorer overall survival compared with MVR group. Prospective studies that address whether inducing MVR by early AVT improves patient outcome are warranted.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
lty发布了新的文献求助10
刚刚
6秒前
王翎力完成签到,获得积分10
12秒前
elisa828发布了新的文献求助10
32秒前
万能图书馆应助Ggap1采纳,获得10
41秒前
活力的珊完成签到 ,获得积分10
1分钟前
YY完成签到,获得积分10
1分钟前
elisa828发布了新的文献求助10
1分钟前
科研通AI2S应助科研通管家采纳,获得10
1分钟前
1分钟前
科研通AI2S应助科研通管家采纳,获得10
1分钟前
Owen应助科研通管家采纳,获得200
1分钟前
Ava应助青柏采纳,获得10
1分钟前
科研通AI2S应助sugarmei采纳,获得10
1分钟前
王洋洋完成签到 ,获得积分10
1分钟前
2分钟前
2分钟前
青柏发布了新的文献求助10
2分钟前
冬1完成签到 ,获得积分10
2分钟前
JackFan完成签到,获得积分10
2分钟前
2分钟前
游01完成签到 ,获得积分10
2分钟前
3分钟前
3分钟前
cappuccino完成签到 ,获得积分10
3分钟前
无限的以亦完成签到,获得积分10
3分钟前
Kevin完成签到,获得积分10
4分钟前
ChatGPT完成签到,获得积分10
4分钟前
zzhui完成签到,获得积分10
4分钟前
4分钟前
4分钟前
4分钟前
4分钟前
elisa828发布了新的文献求助10
5分钟前
adinaaaalala关注了科研通微信公众号
5分钟前
朴实以丹完成签到 ,获得积分10
5分钟前
情怀应助科研通管家采纳,获得10
5分钟前
Owen应助科研通管家采纳,获得10
5分钟前
cadcae完成签到,获得积分10
6分钟前
GYQ完成签到,获得积分20
6分钟前
高分求助中
A new approach to the extrapolation of accelerated life test data 1000
Cognitive Neuroscience: The Biology of the Mind 1000
Technical Brochure TB 814: LPIT applications in HV gas insulated switchgear 1000
Immigrant Incorporation in East Asian Democracies 600
Nucleophilic substitution in azasydnone-modified dinitroanisoles 500
不知道标题是什么 500
A Preliminary Study on Correlation Between Independent Components of Facial Thermal Images and Subjective Assessment of Chronic Stress 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3968520
求助须知:如何正确求助?哪些是违规求助? 3513331
关于积分的说明 11167298
捐赠科研通 3248700
什么是DOI,文献DOI怎么找? 1794417
邀请新用户注册赠送积分活动 875030
科研通“疑难数据库(出版商)”最低求助积分说明 804664